Keyphrases
Deferoxamine
100%
Vascular Function
100%
Fracture Healing
100%
Radiotherapy
100%
Pathologic Fracture
100%
Bony Union
100%
Angiogenesis
36%
Nonunion
27%
Tubule Formation
27%
High Dose
18%
Pharmacologic
18%
Human Equivalent Dose
18%
Remediate
18%
Microcomputed Tomography
9%
Clinically Significant
9%
Increased Incidence
9%
Deleterious Effects
9%
Operative
9%
Sprague-Dawley Rats
9%
Osteotomy
9%
Fractionated Radiotherapy
9%
Incubation
9%
Radiation Effects
9%
Therapeutic Potential
9%
Matrigel
9%
Fracture Repair
9%
Group Control
9%
Mandible
9%
Long Bone
9%
Vascular Density
9%
Mandibular Fracture
9%
External Fixator
9%
Robust Networks
9%
Alternative Treatment Strategies
9%
New Vessels
9%
Vessel Formation
9%
Fracture Callus
9%
Experiment in Vivo
9%
In Vitro Investigation
9%
HUVEC Cells
9%
Corrosion Effect
9%
Iron Chelating Agents
9%
Medicine and Dentistry
Deferoxamine
100%
Vascularity
100%
Fracture Healing
100%
Pathologic Fracture
100%
Radiation Therapy
100%
Angiogenesis
36%
In Vitro
27%
Nonunion
27%
Drug Megadose
18%
Equivalent Dose
18%
X-Ray Microtomography
9%
Low Drug Dose
9%
Incubation
9%
Osteotomy
9%
Callus
9%
Matrigel
9%
Mandible Fracture
9%
Iron Chelating Agent
9%
Pharmacology, Toxicology and Pharmaceutical Science
Fracture Healing
100%
Deferoxamine
100%
Pathologic Fracture
100%
Fracture Nonunion
27%
Sprague Dawley Rat
9%
Callus
9%
Matrigel
9%
Mandible Fracture
9%
Iron Chelating Agent
9%